We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

157 hedge funds and large institutions have $403M invested in Anika Therapeutics in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 75 increasing their positions, 34 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 34

3.92% more ownership

Funds ownership: 89.83% → 93.75% (+3.9%)

3% less funds holding

Funds holding: 162 → 157 (-5)

6% less capital invested

Capital invested by funds: $429M → $403M (-$25.6M)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

43% less call options, than puts

Call options by funds: $6.65M | Put options by funds: $11.6M

Holders
157
Holders Change
-5
Holders Change %
-3.09%
% of All Funds
3.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
75
Reduced
34
Closed
22
Calls
$6.65M
Puts
$11.6M
Net Calls
-$4.99M
Net Calls Change
-$4.69M

Top Buyers

1
Ameriprise
Ameriprise
Minnesota
+$15M
2
State Street
State Street
Massachusetts
+$7.72M
3
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management
California
+$5.98M
4
Baird Financial Group
Baird Financial Group
Wisconsin
+$5.44M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.14M

Top Sellers

1
First Manhattan
First Manhattan
New York
-$13.8M
2
EC
Engaged Capital
California
-$12.6M
3
AAM
AMI Asset Management
California
-$10.8M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.5M
5
PCM
Portolan Capital Management
Massachusetts
-$3.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
51
Russell Investments Group
United Kingdom
$1.05M +$211K +6,169 +21%
Legal & General Group
52
Legal & General Group
United Kingdom
$1.02M +$109K +3,172 +10%
American Century Companies
53
American Century Companies
Missouri
$946K +$1.07M +31,281 New
PWLP
54
Prio Wealth Limited Partnership
Massachusetts
$931K -$34.2K -1,000 -3%
TA
55
Teachers Advisors
New York
$911K +$77K +2,247 +8%
TCIM
56
TIAA CREF Investment Management
New York
$892K – – –
EGM
57
Engineers Gate Manager
New York
$890K +$1.01M +29,423 New
Acadian Asset Management
58
Acadian Asset Management
Massachusetts
$862K +$977K +28,517 New
Swiss National Bank
59
Swiss National Bank
Switzerland
$771K – – –
BIM
60
Bridges Investment Management
Nebraska
$745K +$165K +4,830 +24%
KBC Group
61
KBC Group
Belgium
$724K +$444K +12,969 +118%
JP Morgan Chase
62
JP Morgan Chase
New York
$723K +$101K +2,936 +14%
PI
63
PineBridge Investments
New York
$714K +$808K +23,602 New
ASRS
64
Arizona State Retirement System
Arizona
$663K +$1.27K +37 +0.2%
AllianceBernstein
65
AllianceBernstein
Tennessee
$647K – – –
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$643K -$19.6K -573 -3%
Rafferty Asset Management
67
Rafferty Asset Management
New York
$625K +$708K +20,658 New
IP
68
Isthmus Partners
Wisconsin
$572K -$667K -19,478 -87%
Assenagon Asset Management
69
Assenagon Asset Management
Luxembourg
$570K -$1.28M -37,379 -66%
Jacobs Levy Equity Management
70
Jacobs Levy Equity Management
New Jersey
$567K +$642K +18,748 New
CM
71
CS McKee
Pennsylvania
$555K -$5.14K -150 -0.8%
Envestnet Asset Management
72
Envestnet Asset Management
Illinois
$536K +$213K +6,227 +54%
Barclays
73
Barclays
United Kingdom
$506K +$350K +10,216 +157%
AQR Capital Management
74
AQR Capital Management
Connecticut
$480K +$26.5K +775 +5%
BTS
75
BB&T Securities
Virginia
$474K +$269K +7,846 +100%
1 2
3
4 5

ANIK Hedge Fund Activity: Q1 2019 in Review

157 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2019, worth a combined $403M — down 6% from $429M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ANIK and 19 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 75 added.

The largest buyer was Ameriprise, adding an estimated $15M. The largest seller was First Manhattan, exiting entirely with an estimated $13.8M sold.

  • 157 institutional investors held Anika Therapeutics (ANIK) as of Q1 2019, down from 162 in Q4 2018.
  • Funds reported $403M of Anika Therapeutics stock for Q1 2019, down 6% quarter-over-quarter.
  • 19 funds opened new Anika Therapeutics positions in Q1 2019 and 22 closed out, a net change of -3 holders.
  • The largest Anika Therapeutics buyer in Q1 2019 was Ameriprise, an estimated $15M added.
  • The largest Anika Therapeutics seller in Q1 2019 was First Manhattan, an estimated $13.8M sold.

Based on aggregated 13F filings for Q1 2019.